Dianthus Therapeutics
(NASDAQ) DNTH
Dianthus Therapeutics Financials at a Glance
Market Cap
$4.48B
Revenue (TTM)
$2.04M
Net Income (TTM)
$0.00
EPS (TTM)
$-4.11
P/E Ratio
-20.56
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$86.26
Volume
37,999
Open
$83.14
Price
$86.26
Volume
37,999
Open
$83.14
Previous Close
$86.26
Daily Range
$83.14 - $87.34
52-Week Range
$13.37 - $88.49
Dividend
$0.00
Beta (Volatility)
0.99 (Low)
Price
$86.26
Volume
37,999
Open
$83.14
Previous Close
$86.26
Daily Range
$83.14 - $87.34
52-Week Range
$13.37 - $88.49
DNTH News
DNTH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Dianthus Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
92
CEO
Marino Garcia, MBA
Website
dianthustx.comHeadquarters
New York City, NY 10036, US
DNTH Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-87%
Net Income Margin
0%
Return on Equity
-38%
Return on Capital
-36%
Return on Assets
0%
Earnings Yield
-4.86%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.48B
Shares Outstanding
52.94M
Volume
38.00K
Short Interest
0.00%
Avg. Volume
1.08M
Financials (TTM)
Gross Profit
$2.04M
Operating Income
$177.93M
EBITDA
$177.93M
Operating Cash Flow
$129.06M
Capital Expenditure
$213.00K
Free Cash Flow
$129.27M
Cash & ST Invst.
$404.30M
Total Debt
$1.39M
Dianthus Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$284.00K
-78.6%
Gross Profit
$284.00K
-78.6%
Gross Margin
100.00%
N/A
Market Cap
$4.48B
N/A
Market Cap/Employee
$57.39M
N/A
Employees
78
N/A
Net Income
$97.91M
+444.3%
EBITDA
$69.28M
-117.6%
Quarterly Fundamentals
Net Cash
$402.91M
+47.2%
Accounts Receivable
$102.00K
-87.4%
Inventory
$0.00
N/A
Long Term Debt
$1.02M
-13.0%
Short Term Debt
$367.00K
+14.7%
Return on Assets
0.00%
N/A
Return on Invested Capital
-35.57%
N/A
Free Cash Flow
$47.12M
-71.5%
Operating Cash Flow
$46.98M
-71.2%